MTOR and familial pancreatic carcinoma: Furthermore, a simultaneous therapy of mechanistic target of rapamycin kinase (mTOR) inhibitor with GANT61 was confirmed as a more effective treatment for pancreatic cancer by inhibition of the stemness of pancreatic cancer stem cells (Miyazaki et al., 2016).